General Information
DRAVP ID DRAVPe00609
Peptide Name MT-SC19EK
Sequence MTWEEWDKKIEEYTKKIEELI
Sequence Length 21
UniProt ID Q5DP94
Source Synthetic construct
Activity Information
Target Organism HIV
Assay dual split-protein (DSP)-based cell-cell fusion assay,luciferase assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target membrane
Mechanism The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.
Structure Information
PDB ID None
Predicted Structure Download DRAVPe00609
Linear/Cyclic Linear
N-terminal Modification Acetylation
C-terminal Modification Amidation
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C126H193N27O39S
Absent amino acids ACFGHNPQRSV
Common amino acids E
Mass 2742.14
Pl 4.55
Basic residues 4
Acidic residues 7
Hydrophobic residues 6
Net charge -3
Boman Index -5037
Hydrophobicity -120.95
Aliphatic Index 74.29
Half Life
Extinction Coefficient cystines 12490
Absorbance 280nm 624.5
Polar residues 3
Literature Information
Literature 1
Title Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.
Pubmed ID 31277353
Reference Viruses. 2019 Jul 3;11(7):609.
Author Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y.